Thomas D B, Whitehead J, Dorse C, Threatt B A, Gilbert F I, Present A J, Carlile T
Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, WA 98104.
J Natl Cancer Inst. 1993 Feb 3;85(3):230-5. doi: 10.1093/jnci/85.3.230.
Women with proliferative benign breast lesions are at increased risk of breast cancer, and some studies have provided evidence that microscopic calcifications in such lesions enhance the risk.
This study was performed to determine whether calcifications on mammograms are predictive of subsequent breast cancer.
Data for this study were collected on women enrolled at four of the clinics that participated in the Breast Cancer Detection and Demonstration Project (BCDDP). The presence, morphology, and distribution of calcifications visualized on baseline mammograms for 686 women who developed breast cancer over a 7- to 10-year period of follow-up were compared with those for 1357 controls who remained cancer free. We also compared presence and types of calcifications in breasts in which cancer subsequently developed with those in the contralateral breast.
Calcifications were evident at baseline in at least one breast in 381 (55.5%) of 686 cases and in 606 (44.7%) of 1357 controls. The estimated relative risk (RR) of breast cancer was 1.68 in women with calcifications, compared with those having none. There was a statistically significant trend of increasing risk with number of breasts with calcifications; RR increased from 1.28 to 2.14 in women with calcifications in one and both breasts, respectively. In women with unilateral calcifications, RR was greater for the breast in which the calcification occurred (1.48) than for the opposite breast (1.08). The elevated risk persisted for more than 6 years from identification of the calcification, suggesting that these lesions were not indicative of existing carcinomas detected later. Risk was greatest in women with clustered calcifications of any morphology or linearly distributed punctate calcifications (RR = 3.64), and the cancer in women with such calcifications was 4.65 times more likely to occur in the involved breast than in the contralateral breast. Multiple and scattered punctate calcifications, and those of any number or distribution that were ring-shaped or linear, were also associated with subsequent risk of breast cancer (RR = 2.09 and 1.76, respectively) but were not strongly predictive of the side on which the breast cancer occurred. Risk was not altered in women with single punctate or large conglomerate calcifications, although the cancers that subsequently occurred in women with the latter lesions were over three times more likely to develop in the breast with the calcification than in the opposite breast.
These findings are consistent with previously reported relationships between breast cancer and specific histologic types of noninvasive breast lesions. Some types of mammographic calcifications appear to be independent risk factors for breast cancer.
If these results are confirmed by other investigators, mammographic calcifications could serve as an additional indicator of women at high risk for breast cancer who may benefit from intensified follow-up.
患有增生性良性乳腺病变的女性患乳腺癌的风险增加,一些研究已提供证据表明此类病变中的微小钙化会增加风险。
本研究旨在确定乳腺钼靶上的钙化是否可预测后续乳腺癌。
本研究的数据收集自参与乳腺癌检测与示范项目(BCDDP)的四家诊所登记的女性。对686名在7至10年随访期内患乳腺癌的女性基线乳腺钼靶上可见的钙化的存在、形态和分布,与1357名未患癌的对照者进行比较。我们还比较了随后发生癌症的乳房与对侧乳房中钙化的存在情况和类型。
686例病例中有381例(55.5%)在基线时至少一侧乳房有明显钙化,1357名对照者中有606例(44.7%)有钙化。有钙化的女性患乳腺癌的估计相对风险(RR)为1.68,而无钙化者为1。随着有钙化乳房数量的增加,风险有统计学意义的上升趋势;一侧乳房有钙化的女性RR从1.28增加到两侧乳房有钙化的女性的2.14。在单侧有钙化的女性中,发生钙化的乳房的RR(1.48)高于对侧乳房(1.08)。从发现钙化起,风险升高持续超过6年,表明这些病变并非后来检测到的现有癌的指征。任何形态的簇状钙化或线性分布的点状钙化的女性风险最高(RR = 3.64),有此类钙化的女性患癌的乳房比患癌对侧乳房发生癌症的可能性高4.65倍。多个和散在的点状钙化,以及任何数量或分布为环形或线性的钙化,也与后续乳腺癌风险相关(RR分别为2.09和1.76),但对乳腺癌发生在哪一侧的预测性不强。有单个点状或大的团块状钙化的女性风险未改变,尽管有后一种病变的女性随后发生的癌症在有钙化的乳房中发生的可能性比对侧乳房高3倍多。
这些发现与先前报道的乳腺癌与特定组织学类型的非侵袭性乳腺病变之间的关系一致。某些类型的乳腺钼靶钙化似乎是乳腺癌的独立危险因素。
如果这些结果得到其他研究者的证实,乳腺钼靶钙化可作为可能受益于强化随访的乳腺癌高危女性的额外指标。